Tonmya is FDA Approved to Treat Fibromyalgia: CEO Seth Lederman Talks
Tonmya is the first FDA approved drug for use in fibromyalgia in 15 years. Seth Lederman, CEO of Tonix Pharmaceuticals, talked about how the drug was developed, what it does, and when it will become available.
Decoding ME: Big Stakes Genetics Study Puts ME/CFS on Firm Biological Foundation
The DecodeME study puts ME/CFS on a firm biological foundation by highlighting genes that play a prominent role in the brain, the immune system and metabolism.
Jarred Younger Finds a VERY Inflamed Brain in ME/CFS
Geoff's Narration The GIST "We’re seeing things in the front of the brain, we're seeing issues in the back of the brain, we're seeing a lot of things in between…this is a brain-wide issue". It's safe to say that the ME/CFS brain is an inflamed brain." Jarred...
An Inflammation Buster for Long COVID? The Bezisterim Clinical Trial
The new Bezisterin long COVID trials seeks to tamp down inflammation at the source and improve cognitive and fatigue.
Turning the Pain up in Fibromyalgia (and ME/CFS?): The Antibody-Mast Cell Connection
A study suggests that mast cell activation may be a key driver of chronic pain in fibromyalgia. Treatments are suggested.
Fibromyalgia – Are it (and ME/CFS) Autoimmune Diseases?
Goebel explains why he believes fibromyalgia is an autoimmune disease and we look at what that means for treatments.
Has the Right B-cell Depleting Drug Been Found for ME/CFS? Daratumumab Shines in Pilot Study
A B-cell depleter called daratumumab does well in an early trial in ME/CFS. A larger trial is underway.
“Excited Every Day”: Dr. Michael Peluso on LIINC, Long COVID and ME/CFS
Dr. Michael Peluso talks about the LIINC long COVID project, why he's excited every day about long COVID, and what he hopes the next 5 years will bring.
TREATME: the Open Medicine Foundation’s Mammoth ME/CFS and Long COVID Treatment Survey Results
The massive TreatME survey assessed the effectiveness of 150 treatments in ME/CFS and long COVID.
Lives Interrupted Latest Story
Megan
Randolph, United States
Former occupation: Day care worker
$562,824
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
